Warrants (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Jan. 26, 2018 |
Mar. 31, 2018 |
Mar. 31, 2017 |
|
| Class of Warrant or Right [Line Items] | |||
| Warrants exercised | |||
| Warrant to purchase of common stock | 2,288,500 | ||
| Weighted average exercise price of warrants | $ 6.33 | ||
| Weighted average remaining life of warrants | 3 years 7 months 21 days | ||
| Additional paid in capital, fair value of warrant issued | $ 6,215,225 | ||
| Cystic Fibrosis Foundation warrants [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Warrant to purchase of common stock | 1,000,000 | 1,000,000 | |
| Weighted average exercise price of warrants | $ 13.20 | $ 13.20 | |
| Warrant exercisable shares of common stock | 500,000 | 500,000 | |
| Warrant expires date | Jan. 26, 2025 | ||
| Additional paid in capital, fair value of warrant issued | $ 6,215,225 | ||
| Cystic Fibrosis Foundation warrants [Member] | Investment Agreement [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Warrant exercisable shares of common stock | 500,000 | 500,000 | |
| Warrant expires date | Jan. 26, 2025 | ||
| X | ||||||||||
- Definition Warrants exercised. No definition available.
|
| X | ||||||||||
- Definition Warrants weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Date the warrants or rights are exercisable, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|